Navigating a robust regulatory environment, advancing your development program with speed, and accessing a breadth of technical expertise are all critical factors to the success of your program. Aliri provides a range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions. As a result, we will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of seasoned scientists and technical experts.
FEATURED INSIGHTS
-
![GettyImages-1220382102-lab-research]( "Oligonucleotides: Where We Are And Where We Would Like To Go")
This presentation provides an overview of oligonucleotide bioanalysis's current status and future directions. We will look into the advantages and disadvantages of various bioanalytical techniques.
-
![APPROVED Rubber Stamp iStock-1178959563]( "Streamlining The Importing & Exporting Of Biological Samples")
Create a seamless and predictable import and export process by working with experienced bioanalytical laboratory partners, understanding what paperwork samples require, and proactive planning.
-
![Vial drug development.jpg]( "Top 8 Benefits Of Mass Spectrometry Imaging Early In Drug Development")
Here we explore the top 8 benefits of using mass spectrometry imaging in the oncology drug discovery and early development stages.
-
![Gett images-542576580 bio]( "Top 5 Approaches To The Bioanalysis Of Oligonucleotides")
Evaluate the strengths and limitations of each bioanalysis method carefully to choose the most effective strategy for your clinical study.
-
![molecule-1184397025]( "How A Drug's Molecule Type Affects Several Bioanalysis Parameters")
Discover why bioanalytics are crucial to selecting promising drug candidates during development and to characterizing the pharmacokinetic and pharmacodynamic profile of the drug in early clinical trials.
-
![GettyImages-974024224-molecule string-molecule cluster]( "7 Crucial Steps In Bioanalysis To Optimize Drug Development")
On the journey toward creating effective therapies, the development of a rugged method for optimizing small molecule drug development strategies plays a pivotal role.
-
![molecule-1184397025]( "Understanding The Intricacies Of qMSI")
Explore quantitative mass spectrometry imaging (QMSI) and leading spatial bioanalysis and biology services that offers one-on-one support throughout your drug development process.
-
![GettyImages-1183908006 bioanalysis]( "The Future Of Small And Large Molecule Bioanalytics")
Learn how innovative, emerging technologies are revolutionizing the field of bioanalytics and drug development.
-
![GettyImages-1371704947 spatial imaging]( "Validating The Efficacy Of A Compound With Spatial Imaging")
Discover how target and efficacy validation can translate into substantial savings and market advantages for sponsors as a result of shortened development and approval timelines.
CONTACT INFORMATION
Aliri Bioanalysis
4720 Forge Road, Suite 108
Colorado Springs, CO 80907
UNITED STATES
Phone: +1 (719) 593-1165
Fax: +1 (719) 593-1625
WEBINARS AND VIDEOS
-
![Why Is Whole-Body PK Important]( "Early-Phase Whole-Body PK")
Accelerate your path to the clinic with Aliri’s cost-effective, label-free whole-body PK service — designed to deliver deeper insights, faster decisions, and better outcomes for your drug candidates.
-
![Label-Free Whole-Body Pharmacokinetics]( "Label-Free Whole-Body Pharmacokinetics")
This approach enables tissue-level analysis, delivering insights into efficacy at the site of action, uncovering potential safety concerns, and supporting smarter clinical candidate selection.
-
![What Is Causing Limited Bioavailability]( "What Is Causing Limited Bioavailability")
Discover how this label-free whole-body QMSI combined with plasma LC-MS/MS can help identify the root causes of limited bioavailability and guide smarter optimization strategies early in development.
-
![aliri harnessing ai thumb]( "Optimal Tech For Predicting Drug Responses At The Cellular Level")
Explore how preserving spatial molecular information and leveraging AI-driven spatial-omics can transform treatment prediction, patient stratification, and personalized medicine.
-
![LC MS Method For The Measurement Of Ornithine Carbamoyl Transferase Enzymatic]( "LC/MS Method For Measurement In Human Plasma")
According to the researchers, this plasma-based measurement has the potential to serve as a critical pharmacodynamic biomarker, facilitating the assessment of novel therapeutic approaches.
-
![LMSMS Analysis Of Coproporphyrin And Coproporphyrin III In Human Plasma]( "LC/MS/MS Analysis Of Coproporphyrin 1, Coproporphyrin 3 In Human Plasma")
This innovative approach holds promise for reducing the need for extensive clinical drug-drug interaction studies, potentially streamlining the drug development process.
-
![Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup]( "Validation Of An LCMS Hybrid Assay With EVOSEP Cleanup")
By leveraging this innovative combination, the assay achieves detection limits comparable to traditional methodologies while enhancing overall efficiency and reliability.
-
![Antisense]( "Antisense Oligonucleotide Extraction Optimization Reveals Differences")
Our findings provide critical insights into refining ASO extraction protocols, which can enhance the accuracy of downstream analyses and support further research into ASO-based therapeutics.
-
![Tissue Adenosine Distribution-Guided Gene Selection]( "Tissue Adenosine Distribution-Guided Gene Selection")
Unlike conventional predictive biomarkers, which often focus on isolated molecular markers, this strategy integrates spatial metabolomics and genomics, providing a multidimensional perspective.
-
![aliri teaser]( "Webinar Teaser: LBA Vs. LC-MS")
Why are so many sponsors shifting from Ligand-Binding Assays (LBA) to Liquid Chromatography-Mass Spectrometry (LC-MS) for large molecule protein analysis?
FEATURED SOLUTIONS
-
![GettyImages-1069859094-IV-bag-intravenous]( "Validated Non-Proprietary Assay (NPA) List")
Our extensive portfolio includes a wide range of validated, off-the-shelf assays designed to support various research applications, ensuring flexibility and efficiency in your projects.
-
![molecule model-GettyImages-692883406]( "Advancing Your Molecule With Speed And Agility")
We offer a comprehensive suite of bioanalytical and spatial biology solutions designed to support the progression of your molecule from discovery through clinical development and product approval.
-
![GettyImages-1334095553-vial-computer-data-pipette-scientist-lab]( "Toxicity Studies")
Utilizing statistical analysis and a proprietary metabolomics database, see how we detect and identify molecular toxicity markers, providing critical safety insights into potential drug candidates.
-
![DNA molecule-GettyImages-2148124383]( "LC/MS/MS Vs. LC/HRMS: Identifying And Quantifying Oligonucleotides")
As OGNT-based therapeutics continue to gain traction in drug development, precise identification and quantification are essential for ensuring their efficacy and safety.
-
![molecular-structure-abstract-molecule-GettyImages-1367697458]( "ATP Detection By Quantitative Mass Spec Imaging (QMSI)")
By leveraging this approach, researchers can streamline workflows, reduce costs, and enhance the efficiency of their bioanalytical processes.
-
![GettyImages-1364253107-dog-cat-animal]( "Bioanalytical Services For Animal Health")
Our longstanding relationships with regulatory agencies ensure that we provide high-quality, compliant bioanalytical solutions that meet the rigorous standards necessary for drug approval.
-
![GettyImages-1397698830 Female scientist working on antiviral drug in laboratory]( "Drug Discovery Bioanalytical Solutions: Quick Turnarounds For Lead Optimization")
Leverage rapid, high-quality discovery bioanalysis to streamline your drug development process, optimize lead compounds, and meet evolving timelines with confidence.
-
![Multi pipette, sample preparation, bioassay, in vitro cell-GettyImages-2058885436]( "Quantitative PCR (qPCR)")
With decades of experience in molecular assay development for biomarker and PK/PD studies, our scientific team collaborates closely with sponsors to design tailored solutions.
